文献速递心律失常心力衰竭与心肌病

致心律失常性右心室心肌病风险分层综述

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
PubMed 文献 · Circulation · 2017-01-01

本文综述了致心律失常性右心室心肌病(ARVC)风险分层的文献,结合三位作者终身诊疗经验,指出诊断后最关键决策是是否植入ICD以预防心源性猝死,并总结电不稳定、先证者状态、结构病变范围、晕厥、男性、多突变或TMEM43突变及运动限制意愿等重要参数。

要点

  • ARVC诊断后核心决策是评估猝死风险是否足以植入ICD。
  • 室性早搏频率、持续性室性心律失常等电不稳定指标是风险分层关键。
  • 先证者状态、结构病变范围、晕厥、男性、多突变或TMEM43突变及运动限制意愿均需考虑。

核心结论

  • ARVC患者诊断后最关键临床决策是评估猝死风险是否足以植入ICD,需综合电不稳定、先证者状态、结构病变范围、晕厥、男性、多突变或TMEM43突变及运动限制意愿等参数。

研究设计与样本

  • 本文为文献综述,结合三位作者终身诊疗经验,检索范围未明确报告。

主要发现

  • ARVC是遗传性心肌病,以室性心律失常和猝死风险增加为特征,左心室受累常见且存在左优势型。
  • 病理特征为心肌细胞丢失伴纤维脂肪替代。
  • 猝死可能为首发表现,且ARVC是年轻人猝死常见原因。
  • ICD可挽救生命但伴随短期和长期并发症。

关键数值与推荐

  • 风险分层重要参数包括室性早搏频率和持续性室性心律失常、先证者状态、结构病变范围、心脏晕厥、男性、多突变或TMEM43突变及限制运动意愿。

临床怎么用

  • 临床中应基于上述参数综合评估ARVC患者猝死风险,结合患者偏好和价值观决定是否植入ICD。

局限性

  • 本文为综述,检索范围未明确报告,证据基于文献和作者经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by ventricular arrhythmias and an increased risk of sudden cardiac death. Although structural abnormalities of the right ventricle predominate, it is well recognized that left ventricular involvement is common, particularly in advanced disease, and that left-dominant forms occur. The pathological characteristic of ARVC is myocyte loss with fibrofatty replacement. Since the first detailed clinical description of the disorder in 1982, significant advances have been made in understanding this disease. Once the diagnosis of ARVC is established, the single most important clinical decision is whether a particular patient's sudden cardiac death risk is sufficient to justify placement of an implantable cardioverter-defibrillator. The importance of this decision reflects the fact that ARVC is a common cause of sudden death in young people and that sudden death may be the first manifestation of the disease. This decision is particularly important because these are often young patients who are expected to live for many years. Although an implantable cardioverter-defibrillator can save lives in individuals with this disease, it is also well recognized that implantable cardioverter-defibrillator therapy is associated with both short- and long-term complications. Decisions about the placement of an implantable cardioverter-defibrillator are based on an estimate of a patient's risk of sudden cardiac death, as well as their preferences and values. The primary purpose of this article is to provide a review of the literature that concerns risk stratification in patients with ARVC and to place this literature in the framework of the 3 authors' considerable lifetime experiences in caring for patients with ARVC. The most important parameters to consider when determining arrhythmic risk include electric instability, including the frequency of premature ventricular contractions and sustained ventricular arrhythmia; proband status; extent of structural disease; cardiac syncope; male sex; the presence of multiple mutations or a mutation in TMEM43; and the patient's willingness to restrict exercise and to eliminate participation in competitive or endurance exercise.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Calkins H, Corrado D, Marcus F, et al. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2017. PMID: 29158215. doi:10.1161/CIRCULATIONAHA.117.030792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。